By proceeding, you agree to our Terms of Use and Privacy Policy.
Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.
28-30 March 2022
The 10th Neurodegenerative Disease Drug Development Summit will be discussing, debating and exploring pivotal neurodegenerative disease research from the past 12 months.
Event Ended
USA
Paid
Boston
18-20 April 2022
The 4th Neuroimmunology Drug Development Summit is the unmissable, industry forum exclusively focused on drug discovery and development targeting neuroimmunological mechanisms.
24-26 May 2022
Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for drug develo
21-23 March 2023
Generate solution-focused strategies surrounding patient access, reimbursement, commercialization, launch, partnering and more. Join experts from across the rare disease community to unite in areas of unmet medical need and create life-transforming t
Hybrid
Philadelphia
05-08 September 2023
Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit, the highly anticipated gathering that brings together over 600 senior decision makers in the field of biomarkers and companion diagnostics (CDx). This industry-led meeting aims to acc